Cargando…
Dissecting FGF Signalling to Target Cellular Crosstalk in Pancreatic Cancer
Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis with a 5 year survival rate of less than 8%, and is predicted to become the second leading cause of cancer-related death by 2030. Alongside late detection, which impacts upon surgical treatment, PDAC tumours are challenging to treat due to...
Autores principales: | Carter, Edward P., Coetzee, Abigail S., Tomas Bort, Elena, Wang, Qiaoying, Kocher, Hemant M., Grose, Richard P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068358/ https://www.ncbi.nlm.nih.gov/pubmed/33918004 http://dx.doi.org/10.3390/cells10040847 |
Ejemplares similares
-
Purinergic GPCR-integrin interactions drive pancreatic cancer cell invasion
por: Tomas Bort, Elena, et al.
Publicado: (2023) -
Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 1
por: Coetzee, Abigail S., et al.
Publicado: (2022) -
Correction: Nuclear FGFR1 promotes pancreatic stellate cell-driven invasion through up-regulation of Neuregulin 1
por: Coetzee, Abigail S., et al.
Publicado: (2023) -
Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion
por: Coleman, Stacey J, et al.
Publicado: (2014) -
Anti‐stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma
por: Carapuça, Elisabete F, et al.
Publicado: (2016)